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ABSTRACT
In vitro fertilization (IVF) has been associated with poor neonatal outcomes. Preterm birth, 
small-for-gestational age (SGA), and low birth weight (LBW) rates are approximately twice 
as high in IVF pregnancies than in natural pregnancies. The IVF procedures have become 
more routine in recent years in Indonesia, but there have been few assessments of 
neonatal outcomes. The study aimed to evaluate the risk of preterm birth, SGA, and LBW 
in IVF infants. This was a retrospective cohort study performed in Dr. Sardjito General 
Hospital, Yogyakarta from January 2012 to December 2016. Pre-coded questionnaires 
were used to collect data from medical records. The relative risk of preterm birth, SGA, 
and LBW among IVF infants were calculated and compared to naturally conceived infants. 
A total sampling method was used for the IVF infants and a simple random sampling 
method was used for naturally conceived infants, who were born on the same day as an 
infant in the IVF group.
A total of 108 infants were recruited, consisting of 54 IVF infants and 54 naturally 
conceived infants. The IVF infants had increased risk of preterm birth (RR = 2.0; 95%CI 
0.52 - 7.58) and LBW (RR = 1.25; 95%CI 0.53 - 2.92). However, the IVF infants did 
not have an increased risk of SGA (RR = 1.0; 95%CI 0.21 - 4.73). In conclusion, the 
risk of preterm birth and LBW in IVF infants are higher than in naturally conceived infants, 
but not statistically significant. However, there is no increased risk of SGA in IVF infants.
ABSTRAK
Fertilisasi in vitro (FIV) dihubungkan dengan luaran neonatus yang rendah. Tingkat 
kelahiran preterm, bayi kecil untuk usia kehamilan, berat badan lahir rendah sekitar dua 
kali lebih tinggi pada kehamilan FIV dibandingkan kehamilan normal. Teknik FIV telah rutin 
dilakukn di Indonesia beberapa tahun belakangan ini, tetapi sedikit dilakukan penilaian 
terhadap luaran neonatusnya. Penelitian ini dilakukan bertujuan untuk mengkaji risiko 
kelahiran preterm, bayi kecil untuk usia kehamilan, berat badan lahir rendah pada anak 
dengan FIV. Penelitian ini merupakan penelitian kohort retrospektif yang dilakukan di RSUP 
Dr. Sardjito, Yogyakarta dari Januari 2012 sampai Desember 2016. Kuesioner berkode 
digunakan untuk mengumpulkan data dari rekam medik. Risiko relatif kelahiran preterm, 
bayi kecil untuk usia kehamilan, berat badan lahir rendah dihitung dan dibandingkan 
dengan bayi lahir normal. Metode sampling total digunakan untuk bayi dengan FIV dan 
metode sampling acak sederhana digunakan untuk bayi normal yang lahir pada hari yang 
sama. Total sebanyak 108 bayi direkrut yang terdiri dari 54 bayi dengan FIV dan 54 bayi 
normal. Fertilisasi in vitro meningkatkan risiko kelahiran preterm (RR = 2,0; 95%CI 0,52 
– 7,58) dan berat badan lahir rendah (RR = 1,25; 95%CI 0.53 – 2,92). Namun demikian, 
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FIV tidak mempunyai risiko bayi kecil untuk usia kehamilan (RR = 1,0; 95%CI 0,21-
4,73). Dapat disimpulkan, risiko kelahiran preterm dan berat badan lahir rendah pada FIV 
lebih tinggi daripada bayi normal, tetapi tidak berbeda nyata. Namun demikian, tidak ada 
kenaikan risiko terjadinya bayi kecil untuk usia kehamilan. 
Keywords: in vitro fertilization – preterm - small for gestational age - low birth weight – 
relative risk
INTRODUCTION
In vitro fertilization (IVF) is one of several 
assisted reproductive technologies (ART). 
The number of babies conceived through this 
procedure is increasing, with an estimated 
3-5 million IVF babies worldwide.1–3 As the 
number of newborns increase, several studies 
have been conducted to evaluate neonatal 
outcomes of low birth weight (LBW), 
preterm birth, and small-for-gestational age 
(SGA). These outcomes occur almost twice 
as often compared to natural pregnancies, 
even in singleton IVF pregnancies.4–7 
Guidelines provided, to optimize obstetrical 
management and counselling (counseling) of 
Canadian women using ART, and to identify 
areas specific to birth outcomes and ART 
requiring further research. Perinatal outcomes 
of ART pregnancies in subfertile women 
are compared with those of spontaneously 
conceived pregnancies. Perinatal outcomes 
are compared between different types of 
ART. This guideline discusses the adverse 
outcomes that have been recorded in 
association with ART, including obstetrical 
complications, adverse perinatal outcomes, 
multiple gestations, structural congenital 
abnormalities, chromosomal abnormalities, 
imprinting disorders, and childhood cancer.
The Cochrane Library and MEDLINE were 
searched for English-language articles from 
1990 to February 2005, relating to assisted 
reproduction and perinatal outcomes. Search 
terms included assisted reproduction, assisted 
reproductive technology, ovulation induction, 
intracytoplasmic sperm injection (ICSI 
Studies in Taiwan and India reported that the 
prevalence of preterm birth was increased 
in IVF pregnancies compared to natural 
pregnancies.8,9
A study in eight infertility centers in 
Indonesia showed a pregnancy success rate 
of 29.46%.10 In 2014, the IVF program at Dr. 
Sardjito General Hospital, Yogyakarta, had 
a 25.4% pregnancy success rate, while the 
percentage of live births was 19.8%. These 
percentages increased in 2015 to 30.9% and 
25.1%, respectively.11,12 The IVF program in 
Indonesia has existed for approximately 29 
years with an increasing percentage of live 
births, but the data on neonatal outcomes 
remains unclear. Hence, this study aimed to 
evaluate the risk of poor neonatal outcomes in 
IVF infants.
MATERIALS AND METHODS
Subjects
This retrospective cohort study was done 
from January 2012 to December 2016. Infants 
who were born at Dr. Sardjito General Hospital, 
Yogyakarta, through IVF pregnancies (IVF 
group) and natural pregnancies (natural group) 
were recruited as subjects. The infants whose 
mothers underwent IVF procedures outside 
this hospital and those whose medical records 
were not found or incomplete were excluded. 
The data were collected from medical records 
using questionnaires.
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Protocol of study
A total sampling method for IVF infants 
and a simple random sampling method for the 
natural group were used. Naturally conceived 
infants born on the same day as an IVF infant 
underwent simple random sampling for 
inclusion. If no naturally conceived infant 
was found on the same dayas an IVF infant, 
retrieval was extended to up to three days later.
A minimum of 64 subjects was required 
for each group to obtain 90% power with 5% 
significance level. In this study, dependent 
variables were neonatal outcomes, i.e., birth 
weight, gestational age, and birth weight 
according to gestational age, while independent 
variables were the process of fertilization (IVF/
natural). Confounding variables were maternal 
age, parity, and placental abnormalities.
The definition of LBW was weight at 
birth of less than 2,500 g, regardless of the 
gestational age; the definition of SGA was 
birth weight according to gestational age of 
less than 10th percentile on the Lubchenco 
curve. Gestational age was defined as the 
length of pregnancy until the time of delivery. 
By the Dubowitz score, preterm was defined 
as <37 weeks gestational age.13 Maternal age 
was defined as the age of the mother at the 
time of delivery. Parity was defined as the 
number of previous pregnancies that reached 
viable gestational age. Placental abnormalities 
included placental abruptio or placenta previa. 
Faculty of Medicine, Universitas , Yogyakarta
Statistical analysis
Statistical analysis was done using 
SPSS Statistics 20. Univariate analysis was 
performed on numerical data and was shown 
as mean or median, while categorical data 
was displayed in proportion. Chi-square or 
Fisher’s exact tests were used to compare 
independent and dependent variables, with 
relative risk as a measure of the strength of 
the relationship. Statistical significance was 
defined to be p<0.05. Multivariate analysis 
was performed using logistic regression. 
RESULTS
Fifty-eight IVF infants were initially 
screened for this study, but three infants 
were excluded due to their IVF not having 
been performed in Dr. Sardjito General 
Hospital and one due to loss of the medical 
records. Hence, 54 subjects were included in 
the IVF group. No infants born from natural 
pregnancies were excluded, for a total of 54 
naturally conceived subjects (FIGURE 1).
FIGURE 1. Flowchart of subjects recruitment
The characteristics of subjects are shown 
in TABLE 1. The IVF group (88.9%) had a 
greater proportion of parity 0 (nulliparous) 
than the natural group (38.9%). In addition, 
the IVF group (22.2%) had a greater 
proportion of multiple pregnancies than the 
natural group (7.40%), though the proportion 
of singletons (77.8%) was still greater than 
the proportion of multiples (22.2%) in the 
IVF group. Moreover, the IVF group (92.6%) 
had a greater proportion of caesarean section 
deliveries than the natural group (48.1%).
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TABLE 1. Characteristics of IVF and naturally conceived subjects
Characteristics IVF (n = 54)
Natural 
(n = 54)
Maternal age [n (%)] 
• 20-34 years 
• ≥35 years
34 (63.0) 
20 (37.0)
36 (66.7) 
18 (33.3)
Maternal age (mean ± SD years) 33.2 ± 3.74 31.4 ± 5.53
Parity prior to this pregnancy [n (%)]
• 0 
• ≥1
48 (88.9) 
6 (11.1)
21 (38.9) 
33 (61.1)
Gestational age, n (%) 
• Full term 
• Preterm
48 (88.9) 
6 (11.1)
51 (94.4) 
3 (5.60)
Number of fetuses [n (%)] 
• Single 
• Multiple
42 (77.8) 
12 (22.2)
50 (92.6) 
4 (7.40)
Sex [n (%)] 
• Male 
• Female
27 (50.0) 
27 (50.0)
34 (63.0) 
20 (37.0)
Birth weight, n (%) 
• Normal 
• Low
44 (81.5) 
10 (18.5)
46 (85.2) 
8 (14.8)
Birth weight
[median (min-max)/mean (SD)]
2,875.0
(600-3850)
2,928.4
(400)
Birth weight for gestational age, n (%) 
• AGA 
• SGA
51 (94.4) 
3 (5.60)
51 (94.4) 
3 (5.60)
Mode of delivery [n (%)] 
• Vaginal 
• Caesarean section
4 (7.4) 
50 (92.6)
28 (51.9) 
26 (48.1)
Placental abnormalities, n (%) 4 (7.4) 0 (0)
AGA=appropriate for gestational age; SGA=small for gestational age
TABLE 2 shows the bivariate analysis 
between the independent variables and 
preterm. The IVF infants had two times the risk 
of preterm birth than natural infants. However, 
it was not significantly different (95%CI 0.52-
7.58; p=0.48). Other independent variables 
such as maternal age, parity, and placental 
abnormalities had no significantly association 
with the occurrence of preterm birth (p>0.05).
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TABLE 2. Bivariate analysis of independent variables and preterm
Variables Preterm(n=9)
Full term
(n=99)
Bivariate
RR 95% CI p
Fertilization process [n (%)] 
• IVF 
• Natural
6 (11.1)
3 (5.6)
48 (88.9)
51 (94.4) 2.0 0.52-7.58 0.48
Maternal age [n (%)]
• 20-34 years
• ≥35 years
5 (7.1)
4 (10.5)
65 (92.9)
34 (89.5) 0.67 0.19-2.37 0.71
Parity prior to pregnancy [n (%)]
• Nulliparous
• Multiparous
6 (8.7)
3 (7.7)
63 (91.3)
36 (92.3) 1.13 0.29-4.27 1.00
Placental abnormalities [n (%)]
• Yes
• No
1 (25)
8 (7.7)
3 (75)
96 (92.3) 3.25 0.52-20.1 0.29
Bivariate analysis of the independent 
variables and SGA revealed no increased 
risk of SGA in IVF infants (RR=1.0; 95%CI 
0.21- 4.73; p=1.0). Other independent 
variables such as maternal age, parity, and 
placental abnormalities also had no significant 
association with the incidence of SGA 
(TABLE 3).
TABLE 3. Bivariate analysis of independent variables and SGA
Variable SGA (n=6)
AGA 
(n=102)
Bivariate
RR 95%CI p
Fertilization process [n (%)] 
• IVF 
• Natural
3 (5.6) 
3 (5.6)
51 (94.4) 
51 (94.4) 1.0 0.21- 4.73 1.0
Maternal age [n (%)] 
• 20-34 years 
• ≥35 years
3 (4.3) 
3 (7.9)
67 (95.7) 
35 (92.1) 0.54 0.11- 2.56 0.66
Parity prior to this pregnancy [n (%)] 
• Nulliparous 
• Multiparous
3 (4.3) 
3 (7.7)
66 (95.7) 
36 (92.3) 0.56 0.12- 2.67 0.66
Placenta abnormalities [n (%)] 
• Yes 
• No
0 (0) 
6 (5.80)
4 (100) 
98 (94.2) 1.00
SGA=small for gestational age; AGA=appropriate for gestational age
Bivariate analysis of the independent 
variables and LBW revealed that IVF infants 
had 1.2 times higher risk of LBW compared to 
naturally conceived infants. However, it was 
was not significantly different (95%CI 0.53 
- 2.92; p= 0.6). Other independent variables 
such as maternal age, parity, and placental 
abnormalities were not also significantly 
associated with LBW incidence (TABLE 4).
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TABLE 4. Bivariate analysis of independent variables and LBW
Variable LBW (n=18)
NBW 
(n=90)
Bivariate
RR 95%CI p
Fertilization process [n (%)] 
• IVF 
• Natural
10 (18.5) 
8 (14.8)
44 (81.5) 
46 (85.2) 1.25 0.53- 2.92 0.60
Maternal age [n (%)] 
• 20-34 years 
• ≥35 years
10 (14.3) 
8 (21.1)
60 (85.7) 
30 (78.9) 0.67 0.29 -1.57 0.37
Parity prior to pregnancy [n (%)] 
• Nulliparous 
• Multiparous
11 (15.9) 
7 (17.9)
58 (84.1) 
32 (82.1) 0.88 0.37 -2.10 0.78
Placenta abnormalities [n (%)] 
• Yes 
• No
1 (25) 
17 (16.3)
3 (75) 
87 (83.7) 1.53 0.26- 8.82 0.52
LBW: low birth weight; NBW: normal birth weight
Multivariate analysis could not be 
performed in this study due to no variables 
had p values <0.25 after bivariate analysis 
performed.
DISCUSSION
The proportions of preterm infants were 
11.1% and 5.6% in the IVF and natural 
groups, respectively. Similarly, a previous 
study reported that the prevalence of preterm 
ranged from 7.8 to 16.1% in IVF population 
and 4.5% to 8.0% in natural population.14 
Nevertheless, no significant association 
between IVF and preterm (p=0.48) was 
observed, whereas several previous studies 
showed significant results.14,15 Koivurova et 
al.16 found no significant association between 
singleton IVF and preterm (OR 1.5; 95%CI 0.7 
- 3.2), in which the control was only singleton 
pregnancies taken from the general population. 
However, this result became significant when 
both singleton and multiple pregnancies were 
taken as control subjects (OR 5.6; 95%CI 3.7 - 
8.6). As such, sample diversity is an important 
factor in the incidence of preterm.16
All infants from ART procedures may be 
predisposed to preterm birth. Previous studies 
divided ART into subgroups, i.e., fresh with 
frozen embryos, oocyte donors with own 
oocytes, standard IVF with intracytoplasmic 
sperm injection (ICSI), and third day with fifth 
day embryo showed greater risk of preterm, 
LBW and VLBW in each subgroup.17,18 
Maternal morbidity and mortality among 
Swedish women giving birth after in vitro 
fertilisation (IVF) However, Romundstad 
et al.19 also compared natural conception 
with ART in the same mothers and found no 
significant difference. They concluded that 
ART did not harm the perinatal outcome, but 
genetics was more likely to be an underlying 
factor of preterm incidence. Another study 
mentioned that ART pregnancies were 
generally more closely monitored, such 
that birth was more frequently subject to 
induction and caesarean section. These ART 
interventions also have been associated with 
SGA incidence, increased perinatal mortality, 
and VLBW.14
The proportion of SGA in our study was 
similar in both the IVF and natural groups 
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(5.6%). Previous studies reported SGA in 
12.7% of IVF pregnancies and 13% of natural 
pregnancies,20 and 2.89% in both IVF and 
natural newborns.21 In this study, there was no 
increased risk of SGA in IVF infants. However, 
this finding may not be conclusive, as a 
previous meta-analysis stated that the risk of 
SGA in IVF pregnancies was 1.3 times higher 
compared to natural pregnancies (95%CI 1.27 
to 1.53).22 In contrast, other studies stated that 
there was no increased risk of SGA in IVF 
infants.20,21,23 Wen et al.23 noted that general 
and more diverse populations tended to have 
significant influences on SGA incidence. 
The proportions of LBW in our study 
were 18.5% and 14.8% in the IVF and natural 
groups, respectively. Similarly, a previous 
study reported LBW of 11.2% in IVF and 
11.6% in natural newborns.20 Our bivariate 
analysis revealed no significant association 
between IVF and LBW incidence (p=0.60), 
similar to previous studies that compared 
LBW and preterm in ART and non-ART 
groups.20,24 In contrast, a recent meta-analysis 
suggested that LBW tended to occur in the 
IVF population compared to the natural 
population, even if the baby is full term.25 
Differences in the size of the research scale 
may explain our lack of association between 
IVF and LBW, as small-scale research tended 
to get no significant results.20
Placental abnormalities (all placenta 
previa) were only found in our IVF group 
(7.4%), but there were not significantly 
different from the natural population. IVF 
procedures such as cervical catheterization, or 
mechanically- inducing uterine contractions 
may play a major role in implantation in the 
lower uterine segment, thus leading to placenta 
previa.19 Another study explained that high 
concentrations of estradiol hormone in the IVF 
cycle increased complications associated with 
placental aberration by affecting endometrial 
growth and decidualization.26
Several previous studies have noted 
that the underlying factors of preterm, SGA, 
and LBW remain unclear.7,27,28 To date, the 
underlying factors are maternal age, infertility/
subfertility, genetics, as well as the IVF 
technique itself, but we were unable to assess 
for these variables in our study. Furthermore, 
women who undergo ART may differ from 
the general population, as these women 
usually have high socioeconomic status, good 
nutritional status, better antenatal care, and 
sufficient rest during pregnancy. These factors 
are believed to positively affect pregnancy 
and its outcome.24 Another study reported that 
most pregnancies from the IVF program had 
no complications and resulted in the birth of 
healthy babies.29
Several limitations of our study should be 
noted. The small and potentially inadequate 
sample size as well as the retrospective study 
design may have led to information bias. 
The selection of no intervention populations 
(natural populations) appropriate to the IVF 
population WAS also a weakness. Women 
who underwent IVF treatment in this study 
generally had middle to upper economic status 
(because the IVF program in Indonesia is not 
guaranteed by insurance), more routine control, 
consultation, and treatment during pregnancy, 
especially by the obstetrician. Hence, the IVF 
group may have received better attention and 
care than the natural group. Another weakness 
in our study was that some important variables 
such as socioeconomic status and maternal 
education were not recorded completely in the 
medical records, so they were not included in 
the analysis.
CONCLUSION
In conclusion, the risk of preterm birth 
and LBW in IVF infants tend to be higher than 
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in naturally conceived infants. However, they 
are not statistically significant. In addition, 
there is no increased risk of SGA in IVF 
infants. Further research using a larger sample 
size is needed for more representative data of 
the actual conditions in the population.
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